Aegis Capital Still Positive on Rosetta Genomics (ROSG) Following Q4 Results; Nudges Ests Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Rosetta Genomics (ROSG) Files $75M Mixed Shelf
March 23, 2016 4:48 PM EDTRosetta Genomics (NASDAQ: ROSG) filed a registration with the U.S. SEC to sell, from time to time, up to $75 million worth of mixed securities.
... MoreRosetta Genomics (ROSG) Reports Q4 Loss Per Share of $0.14
March 23, 2016 4:16 PM EDTRosetta Genomics (NASDAQ: ROSG) reported Q4 EPS of ($0.14). Revenue for the quarter came in at $3.6 million, versus $698 thousand reported last year.
For earnings history and earnings-related data on Rosetta Genomics (ROSG) click here.
... MoreTrading Radar for 3/23: General Mills (GIS), Fuel Tech (FTEK), KB Home (KBH), StemCells (STEM) Report
March 22, 2016 2:54 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
7:00am EDT
Earnings:
CTI Industries Corp (Nasdaq: CTIB) - no Street consensus... More
